BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17882425)

  • 1. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
    Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
    Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
    Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
    J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
    Goto M; Sakai K; Yokota H; Kiba M; Yoshida M; Imai H; Weiland E; Yokota I; Yamada K
    Eur Radiol; 2019 Mar; 29(3):1164-1174. PubMed ID: 30088064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 Tesla.
    Stehouwer BL; Klomp DW; van den Bosch MA; Korteweg MA; Gilhuijs KG; Witkamp AJ; van Diest PJ; Houwert KA; van der Kemp WJ; Luijten PR; Mali WP; Veldhuis WB
    Eur Radiol; 2013 Nov; 23(11):2961-8. PubMed ID: 23982289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.
    Calabrese M; Brizzi D; Carbonaro L; Chiaramondia M; Kirchin MA; Sardanelli F
    Radiol Med; 2009 Mar; 114(2):267-85. PubMed ID: 19194774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
    Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
    Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
    Pinker-Domenig K; Bogner W; Gruber S; Bickel H; Duffy S; Schernthaner M; Dubsky P; Pluschnig U; Rudas M; Trattnig S; Helbich TH
    Eur Radiol; 2012 Feb; 22(2):322-30. PubMed ID: 21913060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
    Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
    Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
    Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
    Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
    Choi N; Han BK; Choe YH; Kim HS
    J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.